NLRP3 and lung carcinoma: Since it has previously been reported that upon activation, NLRP3 inflammasome induces proteolytic cleavage and conversion of pro-IL-1β to IL-1β (21) and IL-1β, in turn, promotes proliferation and migration of the lung cancer cells (22) as well as tumor growth and angiogenesis (23).